StockNews.com Initiates Coverage on Retractable Technologies (NYSE:RVP)

StockNews.com initiated coverage on shares of Retractable Technologies (NYSE:RVP) in a research report issued on Monday. The firm set a “hold” rating on the stock.

Retractable Technologies Stock Performance

NYSE:RVP opened at $0.80 on Monday. Retractable Technologies has a twelve month low of $0.56 and a twelve month high of $1.34. The company has a quick ratio of 5.92, a current ratio of 8.57 and a debt-to-equity ratio of 0.01. The stock’s 50-day simple moving average is $0.66 and its 200 day simple moving average is $0.86. The firm has a market capitalization of $23.87 million, a PE ratio of -1.48 and a beta of 1.94.

Hedge Funds Weigh In On Retractable Technologies

A hedge fund recently bought a new stake in Retractable Technologies stock. PFG Investments LLC purchased a new position in shares of Retractable Technologies, Inc. (NYSE:RVP) in the 3rd quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The institutional investor purchased 34,600 shares of the company’s stock, valued at approximately $27,000. PFG Investments LLC owned approximately 0.12% of Retractable Technologies as of its most recent filing with the Securities and Exchange Commission (SEC). Institutional investors own 7.58% of the company’s stock.

About Retractable Technologies

Retractable Technologies, Inc designs, develops, manufactures, and markets safety syringes and other safety medical products for the healthcare profession in the United States, rest of North and South America, and internationally. The company offers VanishPoint insulin syringes; tuberculin, insulin, and allergy antigen syringes; small diameter tube adapters; blood collection tube holders; allergy trays; IV safety catheters; Patient Safe syringes and Luer Caps; VanishPoint blood collection sets; EasyPoint needles; and VanishPoint autodisable syringes.